Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7006503

NCc1cccc(Cn2cc(-c3c[nH]c(=O)n3-c3c[nH]c4ccccc34)c3ccccc32)c1.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TPSAB1 Q15661 12/20 0.43
PRKACA P17612 2/20 0.38
PRKACG P22612 2/20 0.38
PRKACB P22694 2/20 0.38
CAMK2D Q13557 1/20 0.38
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA9 Q16790 2/20 0.37
RPS6KB1 P23443 1/20 0.37
CCNT1 O60563 1/20 0.37
CDK9 P50750 1/20 0.37
MC4R P32245 1/20 0.36
MC5R P33032 1/20 0.36
MC3R P41968 1/20 0.36
CDK4 P11802 1/20 0.36
CCND1 P24385 1/20 0.36
SIRT2 Q8IXJ6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7008945 0.92 PRKACA (0.43) PRKACAPRKACGPRKACBCAMK2DCA12
Trifluoroacetic Acid SCHEMBL6984982 0.87 TPSAB1 (0.40) TPSAB1PRKACAPRKACGPRKACBCAMK2D
Trifluoroacetic Acid SCHEMBL7011017 0.85 CAMK2D (0.54) PRKACAPRKACGPRKACBCAMK2DRPS6KB1
Acetic Acid SCHEMBL7005590 0.79 PRKCB (0.44) TPSAB1CAMK2DCA12CA1CA2
SCHEMBL6980982 0.78 PRKACA (0.39) PRKACAPRKACGPRKACBCAMK2DRPS6KB1
Trifluoroacetic Acid SCHEMBL6983051 0.78 CAMK2D (0.46) PRKACAPRKACGPRKACBCAMK2DRPS6KB1
SCHEMBL7007072 0.77 PRKCA (0.45) PRKACAPRKACGPRKACBCAMK2DSIRT2
SCHEMBL7007889 0.76 CAMK2D (0.62) PRKACAPRKACGPRKACBCAMK2DRPS6KB1
Trifluoroacetic Acid SCHEMBL7009849 0.74 CAMK2D (0.51) PRKACAPRKACGPRKACBCAMK2DRPS6KB1
SCHEMBL7009039 0.74 PRKACA (0.62) PRKACAPRKACGPRKACBCAMK2DRPS6KB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134886-A1 Pharmaceutically active compounds ASTRAZENECA AB, A SWEDISH CORPORATION 2003-07-17 US disclosed
EP-1042317-B1 Indole derivatives as PKC-inhiboitors ASTRAZENECA AB (SE) 2003-05-14 EP disclosed
US-6492409-B1 SUCH AS 5-(1-(3-AMINOPROPYL)-3-INDOLYL)-1-(3-INDOLYL)-1,3-DIHYDROIMIDAZOL-2-ONE; PROTEIN KINASE C INHIBITORS; HIGH SOLUBILITY; REDUCED COLOR; TREATING INFLAMMATORY AND/OR IMMUNOLOGICAL DISORDERS ASTRAZENECA AB (SE) 2002-12-10 US disclosed
US-6337342-B1 ARYLIMIDAZOLONE DERIVATIVES ASTRAZENECA AB (SE) 2002-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134886-A1 Pharmaceutically active compounds HTR3C, HTR6, CNR1 TPSAB1 107/4885PRKACA 3300/4885PRKACG 3599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.